MCGalan Lab
banner
mcgalanlab.bsky.social
MCGalan Lab
@mcgalanlab.bsky.social
Professor of Organic and Biological Chemistry Interests in Organic Synthesis, Catalysis, Nanomaterials, G4s and Chemical Biology -
Based at School of Chemistry, University of Bristol, UK. http://galanresearch.com
Great to see our team @bristolchem @bowendeng9373, Sofia Oliveira and Kun Yang at the CCS-d3-bridge 2026 meeting
sites.google.com/view/ccs-d-bri… in Japan, where they are presenting their work on virtual tools to predict G4 folding and ligand interactions @AdrianMulholla1 @Spencer_D60
January 21, 2026 at 3:15 PM
Reposted by MCGalan Lab
Out now in @natchembio.nature.com: Xylosyltransferase engineering to manipulate proteoglycans in mammalian cells 🎉 www.nature.com/articles/s41... check out the press release below! #glycotime
January 20, 2026 at 11:08 AM
Excited to see our latest collaboration on the use of hypervalent chalcogenonium organocatalysis for the direct stereoselective synthesis of deoxyglycosides from hemiacetals. @jenniferjohns01 @THansenChem @MukulMahanti pubs.rsc.org/en/content/a...
Hypervalent chalcogenonium organocatalysis for the direct stereoselective synthesis of deoxyglycosides from hemiacetals
Lewis acids are frequently used as catalysts in glycosylation reactions, however these reagents often suffer from significant limitations such as sensitivity to moisture and poor stereocontrol. Chalco...
pubs.rsc.org
January 19, 2026 at 12:23 PM
Reposted by MCGalan Lab
⚠️ New pre-print just dropped!

www.biorxiv.org/content/10.6...

Bump-and-hole engineering has served us exquisitely to develop chemical tools that are specific for individual glycosyltransferases. Now, Yu Liu, Saskia Pieters and lots of colleagues have taken the method a step further!
Iterative Bump-and-hole engineering creates a bioorthogonal reporter for N-acetylglucosaminyltransferase I
Asparagine-linked protein glycosylation is among the most frequent modifications of proteins trafficking through the secretory pathway. These glycans are manufactured in an assembly line process to a common precursor that is then subject to individual modifications with different levels of complexity. An important biosynthetic modulator is the incorporation of N-acetylglucosamine (GlcNAc) at distinct positions in N-linked glycan biosynthesis, commencing with the activity of the glycosyltransferase MGAT1. While mapping of N-glycans to their corresponding protein attachment sites is generally possible, not much is known about the glycoprotein substrate choice for MGAT1 and related transferases. Analogs of GlcNAc with small bioorthogonal tags can be incorporated into N-glycans. However, due to the promiscuity of some GlcNAc transferases, incorporation is of little specificity towards individual positions. Here, we report an iterative bump-and-hole approach in the design of a bioorthogonal precision tool for the activity of MGAT1 in mammalian cells. Structure-informed protein engineering abrogated the activity of MGAT1 towards the nucleotide-sugar UDP-GlcNAc while retaining activity towards bumped, azide-modified analogs. Kinetic and computational analyses using a neural network approach informed the synthesis of a tailored UDP-GlcNAc analog with preferential acceptance by the engineered enzyme. Following substrate biosynthesis, the strategy allowed selective incorporation of a chemical tag on MGAT1 substrate proteins in living mammalian cells with little background incorporation by other GlcNAc transferases. Our work expands the toolbox for glycan-based reporter compounds. ### Competing Interest Statement C.R.B. is a co-founder and scientific advisory board member of GanNA Bio, Neuravid, Firefly Bio, Lycia Therapeutics, Palleon Pharmaceuticals, Enable Bioscience, Redwood Biosciences (a subsidiary of Catalent), OliLux Bio, Grace Science and InterVenn Biosciences. C.R.B. is a member of the Board of Directors of Alnylam, Xaira Therapeutics, Acepodia and OmniAb. Wellcome Trust, https://ror.org/029chgv08, CC2127, 312750/Z/24/Z Cancer Research UK, https://ror.org/054225q67, CC2127, DRCMDP-Nov22/100011 Medical Research Council, https://ror.org/03x94j517, CC2127 UK Research and Innovation, https://ror.org/001aqnf71, EP/X042383/1, EP/Y032527/1, MR/V02213X/1, UKRI2014 Howard Hughes Medical Institute, https://ror.org/006w34k90, CC31920 Children's Tumor Foundation
www.biorxiv.org
January 18, 2026 at 8:57 PM
Wishing everyone a very Happy Christmas and a great start to 2026 from all of us in the Galan group 🎄
December 24, 2025 at 9:40 AM
Just made it back to Bristol in time to celebrate with @CalumHaydon on passing his PhD viva today @BristolChem @BCS_CDT Many congratulations Dr Haydon!!!🥳 Many thanks Clare Mahon and Adam Nobel for examining.
December 9, 2025 at 3:59 PM
Last stop before heading back to Bristol is the Tropical Medicine Microbiology and Immunology meeting by the Kwai river in Kanchanaburi. Jim Spencer @Spencer_D60 and I shared our work on antimicrobials @BristolChem @BristolUni @Bristol_AMR Thanks to @MahidolU for organising.
December 6, 2025 at 7:27 AM
Great start to the Joint International Tropical Medicine Meeting www.jitmm.com with @Spencer_D60 to share our work on glycan-based AMR diagnostics and therapeutics. Such a great opportunity to catch up with friends and collaborators and a bit of local culture. @brisunipress.bsky.social
December 2, 2025 at 1:07 PM
Many congratulations to our own @jenniferjohns01 from @BristolChem @BCS_CDT for winning an award for her poster presentation @rsc.org Organic Chemistry Symposium yesterday. Well done #sugarcatalysis 🥳👏
December 2, 2025 at 3:47 AM
Fantastic visit today to @mupharm in Bangkok. Thanks Dr. Satsawat Visansirikul for hosting and discussing with the exciting work taking place in the pharmacy department.
December 1, 2025 at 3:37 PM
Many thanks S. Kulkarni for organising this One Day Symposium on Chemistry and Biology of Glycans @iitbombay Always a pleasure to come to Mumbai and interact with colleagues and students. @BristolChem @BristolUni Looking forward to exciting opportunities between our institutes.
November 25, 2025 at 4:52 PM
Many congratulations to Bella Law from @Spencer_D60 jointly with our group @BristolChem on passing her MRes Viva today 🥳. Many thanks to @drzoewaller.bsky.social and Angela Nobbs for examining. Wish I could have been there in person to celebrate with you. 🍾
November 24, 2025 at 5:49 PM
Day 2 of the ‘Emerging Trends in Glycoscience and Glycotechnology (ETGG-2025) at Banaras Hindu University continues … delighted to share our latest work on synthetic strategies for oligosaccharide synthesis and applications. @BristolChem and visiting the campus temple
November 22, 2025 at 11:01 AM
Great first day of the Carbo-39 Emerging trends in Glycoscience and Glycotechnology etgg-bhu-2025.in at BHU Varanasi, hosted by @VinodKTiwari6 Ecstatic to be the “Guest of Honour” at today’s Inaugural function. @BristolChem
November 21, 2025 at 5:48 PM
Such a pleasure to be here @IITHyderabad to kick start the chemspirit.com Such a fantastic conference. Many thanks @ASau_Chem and other conveners for the invitation. @BristolChem
November 17, 2025 at 3:47 AM
Many congratulations to @NinaMaiAllen @BristolChem @BCS_CDT on passing her PhD viva today. Many thanks to Chris @Willis_Group and Marco @diantoniogroup.bsky.social for examining 🥳
November 10, 2025 at 6:35 PM
Excited to share our contribution on the development of new fluorescent 2-ethenyl-benzothiazole analogues: drug-like G4 ligands with potent antitrypanosomatid activity with JCMorales, MRaposo @ipbln_csic @Bristolchem @NinaMaiAllen @YJenny_Jiang at al
pubs.acs.org/doi/10.1021/...
Extending Thioflavin T Fluorescence Probe to 2-Ethenyl-benzothiazole Derivatives: Drug-like Quadruplex Ligands with Potent Antitrypanosomatid Activity
Thioflavin T (ThT) is a well-established fluorescence probe with selectivity for G-quadruplex (G4) structures. Over the past few years, G4 ligands have emerged as promising candidates for the development of antiparasitic agents. Building on this concept, we explored extending ThT’s benzothiazole scaffold by introducing various 2-ethenyl aromatic and heteroaromatic moieties, aiming to enhance G4 binding affinity and potential therapeutic effect. A series of benzothiazolium derivatives were synthesized and evaluated for their antiproliferative and antiparasitic activity. Several 2-ethenyl benzothiazole derivatives showed submicromolar activity against Leishmania spp. and Trypanosoma brucei parasites, with up to 200-fold selectivity over MRC-5 human lung fibroblasts. Notably, compound 2b demonstrated remarkable potency, with an IC50 of 0.48 nM and a selectivity index of 46,151 against Leishmania major amastigotes, and an IC50 of 0.019 nM and a selectivity index of 79,206 against T. brucei. In fact, compound 2b demonstrated superior efficacy and selectivity in comparison to the clinically used drugs suramin, fexinidazole, miltefosine, and amphotericin B. Biophysical studies revealed that all tested derivatives exhibited significant G4 stabilization, surpassing ThT. Location of compound 2b inside the nucleus and the kinetoplast, as well as partially in the mitochondria, opens up the possibility of 2b acting against the parasite through binding to G4.
pubs.acs.org
November 5, 2025 at 5:32 PM
Many congratulations to our own @GuiMarczak @BristolChem 🥳 on winning one of the Poster prizes at the recent www.slonmr.si/anna_2025/in.... Such a great meeting on Nucleic Acids Research!!
October 29, 2025 at 12:23 PM
Many congratulations to @jenniferjohns01 @BCS_CDT @BristolChem for winning the Biosynth best oral presentation at the RSC Carbohydrate Winter meeting 2025 www.rsc.org/events/detai... 🥳
September 24, 2025 at 9:15 AM
Really excited to be here in Turku, Finland at the 34th BioCity symposium biocityturku.fi/biocity-sympos… to showcase our latest synthetic tools as bacterial diagnostic tools @BristolChem
https://biocityturku.fi/biocity-sympos…
August 28, 2025 at 5:39 AM
Check out our latest work with @JaviRamSor @AdrianMulholla1 @dengbowen9373 @chemistry_mike @DoudouLu319, Sofia Oliveira and others @bristolchem on a new bridged azobenzene with reversible photocontrolled binding to a G-Quadruplex DNA/Duplex junction. pubs.acs.org/doi/10.1021/...
Bridged Azobenzene Exhibits Fully Reversible Photocontrolled Binding to a G-Quadruplex DNA/Duplex Junction
The ability to selectively control DNA conformation using light as an external stimulus offers unique opportunities to control specific DNA sequences in biological settings and to develop nucleotide-b...
pubs.acs.org
August 7, 2025 at 11:00 AM
Want to learn about sigma hole donor XB and ChB catalysis in oligosaccharide synthesis, have a look at our recent Focus Review.
@MukulMahanti @BristolChem

sciencedirect.com/science/arti...
sciencedirect.com
July 30, 2025 at 12:36 PM
Carbon Dots as an Emergent Class of Sustainable Antifungal Agents | ACS Nano pubs.acs.org/doi/10.1021/...
Carbon Dots as an Emergent Class of Sustainable Antifungal Agents
Carbon-based functional nanomaterials with distinct photoluminescent properties have gained significant attention for their diverse applications in bioimaging, biomedicine, and antimicrobial treatment...
pubs.acs.org
July 17, 2025 at 3:40 PM
Reposted by MCGalan Lab
Congratulations to all the prize winners from the Nucleic Acids Forum 2025! An amazing selection of talks and posters to choose from! Thank you to our prize sponsors Chemgenes and RSC Chemical Biology!
@rscchembio.rsc.org
@mikeboothlab.bsky.social
July 16, 2025 at 11:00 AM
Reposted by MCGalan Lab
As promised, postdoc positions at BristolUni.bsky.social available in homogeneous catalysis and computational chemistry exploring the replacement of palladium catalysts by Earth-Abundant Metals: www.bristol.ac.uk/jobs/find/de...

#ChemSky #CompChemSky #ChemJobs #UKChemJobs
July 11, 2025 at 8:13 AM